Long-term survival rates of cancer patients achieved by the end of the 20th century: a period analysis
about
Screening for testicular cancerEnrichment methods to detect bone marrow micrometastases in breast carcinoma patients: clinical relevanceGene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts.Understanding cardiovascular injury after treatment for cancer: an overview of current uses and future directions of cardiovascular magnetic resonanceCyclooxygenase-2 selective inhibition with NS-398 suppresses proliferation and invasiveness and delays liver metastasis in colorectal cancerRelative survival of childhood and adult medulloblastomas and primitive neuroectodermal tumors (PNETs)CCNA2 is a prognostic biomarker for ER+ breast cancer and tamoxifen resistanceCrk and CrkL present with different expression and significance in epithelial ovarian carcinoma.Using relative survival measures for cross-sectional and longitudinal benchmarks of countries, states, and districts: the BenchRelSurv- and BenchRelSurvPlot-macros.Time trend and age-period-cohort effect on kidney cancer mortality in Europe, 1981-2000.Hormone-replacement therapy influences gene expression profiles and is associated with breast-cancer prognosis: a cohort study.Spermatogenesis associated retrogenes are expressed in the human ovary and ovarian cancers.Partial response to sorafenib treatment associated with transient grade 3 thrombocytopenia in a patient with locally advanced thyroid cancer.In vivo evaluation of a MR-guided 980nm laser interstitial thermal therapy system for ablations in porcine liver.Proteomic footprinting of drug-treated cancer cells as a measure of cellular vaccine efficacy for the prevention of cancer recurrenceMolecular and other novel advances in treatment of metastatic epithelial and medullary thyroid cancersIncidence and relative survival of anaplastic astrocytomas.Conditional survival of cancer patients: an Australian perspective.Toremifene--a promising therapy for the prevention of prostate cancer and complications of androgen deprivation therapy.Tumour M2-PK as a stool marker for colorectal cancer: comparative analysis in a large sample of unselected older adults vs colorectal cancer patients.Control of advanced cancer: the road to chronicity.Meaning making in cancer survivors: a focus group study.Role of plasmacytoid dendritic cells and inducible costimulator-positive regulatory T cells in the immunosuppression microenvironment of gastric cancer.The recursive effects of quality of life and functional limitation among older adult cancer patients: evidence from the Survey of Health, Ageing and Retirement in Europe.Saraca indica bark extract shows in vitro antioxidant, antibreast cancer activity and does not exhibit toxicological effects.Intensive care admission of cancer patients: a comparative analysisMolecular signaling network complexity is correlated with cancer patient survivabilityPatients with brain metastases from gastrointestinal tract cancer treated with whole brain radiation therapy: prognostic factors and survival.Outcomes in Critically Ill Patients with Cancer-Related ComplicationsCost-effectiveness of osteoporosis screening and treatment with hormone replacement therapy, raloxifene, or alendronate.The treatment and outcomes of early-stage epithelial ovarian cancer: have we made any progress?Up-to-date estimates of long-term cancer survival in England and Wales.Combining cohort and period methods for retrospective time trend analyses of long-term cancer patient survival ratesBlood pressure and site-specific cancer mortality: evidence from the original Whitehall study.Gene expression profile analysis of t1 and t2 breast cancer reveals different activation pathwaysKi-67 expression predicts locoregional recurrence in stage I oral tongue carcinoma.The utility of surgical lung biopsy in cancer patients with acute respiratory distress syndrome.Cancer survivorship: evolutionary concept analysis.Effectiveness and cost-effectiveness of meaning-centered group psychotherapy in cancer survivors: protocol of a randomized controlled trial.E2F8, a direct target of miR-144, promotes papillary thyroid cancer progression via regulating cell cycle.
P2860
Q24234059-599A312A-9692-4BA7-8D9F-ADDA6829448AQ24806218-6A07EBB0-6053-4D8E-9C94-A227CCD22B97Q25257621-CBA00001-B139-424D-9806-99453C05D6FAQ26859193-6CAD4FCE-B912-47B0-BC5D-5DF75C70E98EQ28167125-D6AC9D0D-820D-4C86-B88E-D77076E835E3Q28245465-D8420DDA-E35F-431A-B4AC-6EB7FF292D30Q28540790-84771CDC-DD67-4433-94D9-4D8B1A310BC2Q30155850-7CB6770D-7223-4F60-BDA2-3146240B74CDQ30537799-7BBB3ED2-C18E-46D8-90D6-EF6BB38CE1ABQ33242087-0340956D-250C-48E7-A6A2-C9545EF7F9CBQ33248484-10A4DBC0-3A63-411B-B67C-7BF2E19239A8Q33424526-62BDE104-160C-4ECC-9B65-4BE8E31D7152Q33425571-2B51AE20-983A-4EC4-AC37-D79D1866E1C5Q33875347-1D450663-FCAD-4435-AC75-6C9EF4F1E564Q34072332-8183E5B7-5A07-4507-B901-EBFD2189AC06Q34123724-D44F3AE9-7843-45F2-A78E-7BE3A0C20CBDQ34193735-26CF3122-E9B3-47C0-A00F-CE6523B608FBQ34435964-D8A9F0FF-71A9-4DF1-A34F-B1449A46645AQ34497901-D535EF5D-EFF7-4A8A-9389-A5A089FE605CQ34615406-7B37BED5-CF21-40D3-98CC-15384776C051Q34874471-7CF071EB-107A-4C21-B882-C3B5A68E67CFQ35006198-AEC39847-069E-4504-B676-94C7ADE60CCCQ35051504-6AD06473-FB8B-4114-9958-71DEA4896396Q35217948-E9CF4116-0E70-4931-A4B8-859BF3064841Q35230064-B628A4C8-D78C-4711-B302-E758F213865FQ35928866-134C8BEB-90FD-4B4B-987F-C4A2FC40C97FQ36061531-7D7B1C4D-1853-4C76-8435-0C243969929DQ36066128-095A35AA-7175-4DA3-83FE-9F50EA034237Q36169137-DAE531E8-3C8A-4D0C-9B33-0910654061A1Q36416737-690B70A2-18B2-4368-BC5F-C01C3538848BQ36608535-57B4CB18-9F42-4811-9D51-0F4AF94C11AEQ36670767-907D74E6-453C-4AE1-B8D4-273525B59DD3Q36671073-1DBD6196-4677-4415-BF9B-9FC96F446053Q36671113-AD0DD45B-961A-4447-B943-03416E49DC1DQ36702209-29DC511B-A4CC-4ABA-90CB-95EE1F2F68B3Q36936031-44B8CE20-06F2-40E0-91AE-D6AB3630B603Q37028354-4E3D2BB6-5698-49FF-B2C2-12428FC2AF31Q37121857-A5B80EB3-A868-40A0-972A-FECEF5ADF66DQ37616742-566502CE-6434-4535-A7A2-89AD152E5DD7Q37686046-69FC951D-6169-4D7E-9684-24A7653FCDD4
P2860
Long-term survival rates of cancer patients achieved by the end of the 20th century: a period analysis
description
article publié dans la revue scientifique The Lancet
@fr
im Oktober 2002 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published in The Lancet
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в жовтні 2002
@uk
ശാസ്ത്രപ്രബന്ധം
@ml
name
Long-term survival rates of ca ...... 0th century: a period analysis
@en
Long-term survival rates of ca ...... 0th century: a period analysis
@nl
type
label
Long-term survival rates of ca ...... 0th century: a period analysis
@en
Long-term survival rates of ca ...... 0th century: a period analysis
@nl
prefLabel
Long-term survival rates of ca ...... 0th century: a period analysis
@en
Long-term survival rates of ca ...... 0th century: a period analysis
@nl
P1433
P1476
Long-term survival rates of ca ...... 0th century: a period analysis
@en
P304
P356
10.1016/S0140-6736(02)11199-8
P407
P577
2002-10-01T00:00:00Z